AstraZeneca Pharmaceuticals LP recalls Lynparza (olaparib) capsules 50 mg, 112 count bottles, Rx only, Manufactured for: Astra Zeneca Pharmaceuticals LP Wilmin
Recalled March 14, 2018 · FDA recall D-0585-2018 · AstraZeneca Pharmaceuticals
Hazard
Failed Impurities/Degradation Specifications; elevated levels of quality attribute Form L (polymorph). · FDA Class III
Units
18056 bottles
Sold at
Nationwide
Description
Failed Impurities/Degradation Specifications; elevated levels of quality attribute Form L (polymorph).
Product
Lynparza (olaparib) capsules 50 mg, 112 count bottles, Rx only, Manufactured for: Astra Zeneca Pharmaceuticals LP Wilmington, DE 19850 by: Patheon Pharmaceuticals, Inc. Cincinnati OH 45237 Product of Switzerland NDC 0310-0657-58
Manufacturer(s)
AstraZeneca Pharmaceuticals LP
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →